REFERENCES
- Hasler F. Advanced Immunoassays in Clinical Rheumatology: A Call for Innovation and Sup-port from Suppliers. Eur Clin Lab 1996; Octo-ber
- Ward MM. Laboratory Testing for Systemic Rheumatic Diseases. Postgrad Med 1998; 103: 93–100
- Hietarinta M, Lassila 0. Clinical significance of Antinuclear Antibodies in Systemic Rheumatic Diseases. Ann Med 1996; 28: 283–291
- von Mühlen CA,Tan EM. Autoantibodies in the Diagnosis of Systemic Rheumatic Diseases. Semin Arthritis Rheum 1995; 24: 323–358
- Reichlin M. Antibodies to Defined Antigens in the Systemic Rheumatic Diseases. Bull Rheum Dis 1993; 42: 4–6
- Hollingsworth PN, Pummer SC, Dawkins RL. Antinuclear Antibodies. In: Peter J.B., Shoen-feld Y., Autoantibodies. Amsterdam, Lausanne, New York, Oxford, Shannon, Tokyo: Elsevier Science B.V. 1996: 74–90
- Astion ML, Wener MH, Hutchinson K. Ad-vances in Autoantibody Testing. LabMedica International 2000; November/December
- Bayer PM, Bauerfeind S, Bienvenu J, Fabien N., Frei PC, Gilburd B, Heide K-G, Hoier-Madsen M, Meroni PL, Monier JC, Monneret G, Panzeri P, Shoenfeld Y, Spertini F, Wilk A. Multicenter Evaluation Study on a New HEp2 ANA Screening Enzyme Immune Assay. J Autoimmunity 1999; 13: 89–93
- Lehmann H-P, Fuehling I, Ott C, Huedepohl B, Haass M. HEp2 ANA ETA: a New Fully Auto-mated Assay for the Screening of Antinuclear Antibodies. Israel Med. Ass J (IMAJ) 2000; 2: 646–648
- Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Heale LA. Kaplan SR., Liang MH, Luthra HS, Medsger TA jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG. The American Rheumatism Association 1987 Re-vised Criteria for the Classification of Rheu-matoid Arthritis. Arthritis Rheum 1988; 31: 315–324
- Spector TD, Hart DJ, Nandra D et al. Low-level Increases in Serum C-reactive Protein are Pres-ent in Early Osteoarthritis of the Knee and Pre-dict Progressive Disease. Arthritis Rheum 1997; 40: 723–727
- Van Leewen MA, van Rijswijk MH, Sluiter WJ, van Riel PLCM, Kuper IH, van de Putte LBA, Pepys MB, Limburg PC. Individual Re-lationship between Progression of Radiological Damage and the Acute Phase Response in Early Rheumatoid Arthritis. Towards Development of a Decision Support System. J Rheumatol 1997; 24: 20–27.
- Pepys MB, Lanham JG, de Beer FC. C-reactive Protein in Systemic Lupus Erythematosus. In: Hughes G.R.V., ed. Clinics in the Rheumatic Diseases. No.1 ed. Eastbourne: W.B. Saunders Co Ltd 1982; 91–103 (Systemic Lupus Erythe-matosus; Vol. 8).
- Gilburd B, Rauova L, Nesher Y, Shoenfeld Y. A Novel Fully Automated Enzyme Immunoas-say for the Detection of Antibodies against Human B2-glycoprotein I. Israel Med Ass J (IMAJ) 2000; 2 (suppl.): 33
- Alarcon-Segovia D., Mestanza M., Cabiedes J., Cabral A.R. The Antiphospholipid/Cofactor Syndromes. II. A Variant in Patients with Sys-temic Lupus Erythematosus with Antibodies to B2-Glycoprotein I but no Antibodies Detectable in Standard Antiphospholipid Assays. J Rheu-matol 1997; 24: 1545–1551
- Guerin J., Feighery C., Sim R.B., Jackson J. Antibodies to 132-Glycoprotein I — A Specific Marker for the Antiphospholipid Syndrome. Clin Exp Immunol 1997; 109: 304–309
- Bossuyt X., Claeys G., Heide K.-G. Evaluation of an Enzyme Immunoassay for the Detection of Rheumatoid Factors of all Antibody Iso-types. In: K. Conrad, R.-L. Humbel, M. Meurer, Y. Shoenfeld, E.M. Tan (eds.). Autoantigens and Autoantibodies: Diagnostic Tools and Clues to Understanding Autoimmunity. Report on the 5th Dresden Symposium on Autoanti-bodies held in Dresden on October 18–21,2000.
- Haass M., Lehmann H.-P. New Aspects of Autoantibody Detection with a New Combina-tion of Autoantigenic Targets. Int J Immunore-hab 2000; 2 (3): 19–23